Stock Market Opens Flat: BEL, Tata Steel, HCL Tech in Focus
Indian stock markets opened flat on January 8, 2026, amid mixed global cues. Key stocks like BEL, Tata Steel, HCL Tech, Sun Pharma, Maruti, and TCS are in focus. Read the full analysis.
Category : Search result: smallcap pharma stock
Smallcap Stock in Focus After Credit Rating Reaffirmation
Shares of a BSE-listed smallcap company attract investor attention after CARE Ratings reaffirms its credit ratings. Check the latest stock price and details.
Cupid Stock Jumps 11%, Snaps 2-Day Losing Streak
Small-cap multibagger Cupid surged 11% on January 6, recovering from a 35% drop. Read the latest on this volatile stock's market performance.
Cupid shares plunge 20% to lower circuit, snaps 13-day rally
Small-cap stock Cupid tumbled 20% to its lower price band of ₹419.95 on Jan 2, halting a 13-day winning streak amid high volumes. Discover the details and market impact.
Smallcap Stock Under Rs 300 Gains on Major Orders
Shares of a BSE-listed smallcap company surged after securing consecutive orders worth crores. Discover the stock details, financials, and future outlook for investors.
Stock Under Rs 50 Gains 297%, Hits Upper Circuit
A small-cap stock priced under Rs 50 delivered a staggering 297% return in one year, hitting the upper circuit as Indian markets rallied in early trade. Discover the details and key drivers behind this surge.
US Markets Close 2025 Higher Despite Final Session Loss
Wall Street's major indexes fell slightly on the last trading day of 2025 but are set for strong double-digit yearly gains, fueled by AI stocks. Nike and Vanda Pharma saw notable moves.
D-Street's 2025: Nifty Gains 10.6%, Smallcaps See First Drop in 2 Yrs
Indian markets navigated global uncertainty in 2025 with a selective rally. While Nifty 50 gained 10.6%, smallcaps fell 5.6%. DIIs absorbed massive FPI outflows, setting stage for 2026. Read the full analysis.
Smallcap Stock Rises as Board Approves Credit Facility
Shares of a BSE-listed smallcap company surged after its board approved a significant credit facility enhancement. Read the full details and market impact here.
Smallcap Textile Stock Gets Credit Rating Reaffirmation
A BSE-listed smallcap textile company's credit ratings have been reaffirmed by CARE Ratings, signaling financial stability. Check the latest share price details and market impact.
Orange Biotech PCD Pharma Franchise: Lucrative Business Opportunity
Orange Biotech Private Limited unveils a nationwide PCD pharma franchise with high-profit margins, monopoly rights, and extensive product portfolio for entrepreneurs. Start your own pharma business today!
Aurobindo Pharma increases stake in China JV to 50%
Aurobindo Pharma's Dutch arm buys 20% more in China's Luoxin Aurovitas for $5M, aiming for 100% ownership by 2029 to scale up inhalation product manufacturing. Read the full strategic move.
Santa Rally: Smallcaps Set to Outperform Nifty, History Shows
Indian smallcap stocks eye a 3.55% Santa Claus rally with a 100% success rate over a decade. Analysts see technical rebound aligning with seasonal trends. Read more.
India Pharma Targets $500B, Innovation Hub by 2047
India's pharmaceutical industry gears up for a critical 5-year phase from 2026, aiming to become a $500 billion innovation hub by 2047. Learn how it plans to tackle challenges and seize opportunities.
Small-Cap Crash in 2025: Index Falls 9%, 5 Stocks Defy Trend
Small-cap stocks in India face a severe downturn in 2025, with the Nifty Smallcap 100 index down over 9%. Yet, five stocks like Cupid and Force Motors delivered multibagger returns. Experts see a potential 2026 recovery. Read for key insights.
Mangalam Cement stock jumps 10% in Dec amid market fall
Mangalam Cement shares soar 10% in December, outperforming Sensex and Smallcap indices. Strong Q2 results and internal promoter restructuring drive investor confidence. Read the full analysis.
Bangladesh Beats India to Export Weight-Loss Drugs to Emerging Markets
Bangladesh's pharma firms have a 2-year head start over Indian giants like Dr Reddy's in exporting generic semaglutide. Delhi HC allows exports, but domestic sales wait until 2026. Explore the competitive landscape.
Sun Pharma Shares Fall 3% Post-US FDA Inspection
Sun Pharmaceutical shares fell over 3% after a US FDA inspection at its Baska plant. The inspection concluded with 3 observations. Get the full details on the market impact and company's response.
Smallcap Stock Rallies for 6th Day Amid Market Swings
A BSE smallcap stock continues its winning streak for the sixth consecutive day, showcasing resilience despite overall market volatility. Discover the stock's performance and key details.
Corona Remedies IPO Opens: Key Details & Strong GMP
Corona Remedies IPO subscription starts Dec 8. Price band ₹1008-1062, aims to raise ₹655 cr. Grey market premium signals strong investor interest. Details inside.
Corona Remedies IPO Subscription Begins, GMP at ₹290
Corona Remedies' ₹655 crore IPO opens today. With a price band of ₹1,008-₹1,062 and a strong GMP, analysts give a 'Subscribe for long term' rating. Key dates and details inside.
Nivin Pauly's 'Pharma' Trailer Targets Unethical Drug Practices
Nivin Pauly's OTT debut 'Pharma' trailer reveals a medical rep exposing dangerous drugs. The series premieres on JioCinema December 19 in 7 languages. Read more.
Corona Remedies IPO: Key Dates, Price Band, Details
Corona Remedies IPO opens Dec 8, 2025, to raise ₹655.37 crore. Check price band, GMP, financials, and key dates for this pharma company's public issue.
Market Opens Strong: Nifty Above 25,400, Gift Nifty Up
Indian stock markets opened strong on December 3, 2025, with Nifty crossing 25,400. Key stocks like TCS and Sun Pharma in focus. Read for full analysis and trading cues.
Wockhardt Shares Jump 6% on USFDA NDA Acceptance for Zaynich
Wockhardt's share price surged over 6% after the USFDA accepted its New Drug Application for Zaynich, a novel antibiotic. Discover the details and market impact.
Small-Cap Index Falls Over 2.5% in November
Indian small-cap stocks underperformed sharply in November, falling over 2.5% even as the Nifty 50 hit new peaks. Discover the key reasons behind the sell-off and the outlook for 2026. Read more for expert insights.
Pharma Chemical Firms Outperform with 7% Growth
Speciality chemical makers supplying pharma CDMOs post 7% sales growth, outpacing non-pharma peers. Strong margins and global shifts fuel this resilient sector. Read more.
November 2025 IPO Analysis: Market Trends Revealed
November 2025 witnessed 9 IPOs with 12 listings. Groww leads with 58.85% gains while experts warn of investor fatigue and unrealistic valuations. Read full analysis.
Sudeep Pharma Shares Jump 33% After Strong IPO Listing
Sudeep Pharma shares surged 33.78% in market debut, exceeding expectations. Analysts advise partial profit booking while maintaining long-term optimism. Read expert views on buy/sell strategy.
Sudeep Pharma IPO Lists at 23% Premium on NSE, BSE
Sudeep Pharma shares surged 23% in stock market debut today, outperforming grey market expectations. The ₹895-crore IPO was subscribed 93.71 times. Read full analysis.
Page 1 of 4